Clinical trial
Effect of Additional Nebulized Amikacin in Ventilator-Associated Pneumonia Caused by Gram Negative Bacteria
NCT02574130 is registered in ClinicalTrials.gov with Thammasat University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Additional Nebulized Amikacin in Ventilator-Associated Pneumonia Caused by Gram Negative Bacteria
- Lead sponsor
- Thammasat University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2015
- Completion date
- April 30, 2018
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.